FDA approves fecal transplant therapy | KSL.com - KSL.com

WASHINGTON — The Food and Drug Administration on Wednesday approved Switzerland-based Ferring Pharmaceuticals' fecal transplant-based therapy to reduce the recurrence of a bacterial infection, making it the first therapy of its kind to be cleared in the United States.

diff infections, fecal microbiota transplants — classified by the regulator as investigational — have long been the standard of care in the U.S.

"As the first FDA-approved fecal microbiota product, (the) action represents an important milestone, as it provides an additional approved option to prevent recurrent (C. diff infections)," said Peter Marks, director of the agency's Center for Biologics Evaluation and Research.